TGF-β can induce complicated responses in cancer progression, switching from tumor-suppressing by inhibiting cell proliferation at an early stage to pro-oncogenic by promoting EMT and angiogenesis at late stages [48, 49]. Here, TGFB1 is linked to cancer.